Double minutes (DMS) and homogeneously staining regions (HSRS)

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Resistance to antineoplastic drugs may develop through a variety of mechanisms. The unique mechanism for mutation to drug resistance is amplification of the gene coding for a target protein, leading to an elevated level of protein. The process of gene amplification in drug-resistant mammalian cells may occur within a single chromosome, producing an expanded homogeneously staining region (HSR) containing multiple copies of the gene coding for the target enzyme. The amplified genes may also be located in small pieces of DNA called double minutes (DMs). To study this question, we have chosen to examine the mechanisms associated with development of adriamycin resistance in the human breast cell line MCF-7. Adr(R) MCF-7 cells are 200 fold resistant to adriamycin and were produced by exposing the MCF-7 cells to increasing drug concentration through serial passages. These cells are also cross-resistrant to actinomycin D, VP-16, and vinblastine. Cytogenetic studies of the Adr(R) cell line showed the presence of HSRs on chromosome 11 and on a rearranged chromosome 7; neither were present in the parental cell lines. The HSRs became further lengthened with increasing drug concentrations. The presence of HSRs suggested that gene amplification may play a role in this resistant phenotype. Amplified DNA sequences (pA1) representing a total length of over 140 Kb were selected from Adr(R) cell DNA using in-gel hybridization techniques. Furthermore, a 3 Kb cDNA sequence pAdr1 was isolated from these cells by hybridization to each of the HSRs in the Adr(R) cells. In addition both probes hybridized to chromosome 7q21.2 in normal human lymphocytes. Both probes also exhibited some hybridization to chromosome 6pter. Thus the pAdr1 gene (a human p-glycoprotein or mdr-1 gene) resides on human chromosome 7q21.2, a region that also contains CF and C-met.

Original languageEnglish
Title of host publicationHuman tumor markers
Subtitle of host publicationproceedings of the International Symposium on Human Tumor Markers. ICS807
EditorsS.W. Ting, J.-S. Chen, M.K. Schwartz, S.W. Ting, J.-S. Chen, M.K. Schwartz
PublisherElsevier Science Publishers B.V.
Pages63-74
Number of pages12
ISBN (Print)044481065X
Publication statusPublished - Jan 1 1989
Externally publishedYes
EventThe International Symposium on Human Tumor Markers -
Duration: Sep 3 1988Sep 5 1988

Conference

ConferenceThe International Symposium on Human Tumor Markers
Period9/3/889/5/88

Fingerprint

Staining and Labeling
Gene Amplification
Chromosomes
MCF-7 Cells
Cell Line
Doxorubicin
Genes
Neoplasm Drug Resistance
Pharmaceutical Preparations
Serial Passage
Chromosomes, Human, Pair 11
Chromosomes, Human, Pair 7
Vinblastine
DNA
Human Chromosomes
Dactinomycin
Etoposide
Drug Resistance
Cytogenetics
Glycoproteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Whang-Peng, J. (1989). Double minutes (DMS) and homogeneously staining regions (HSRS). In S. W. Ting, J-S. Chen, M. K. Schwartz, S. W. Ting, J-S. Chen, & M. K. Schwartz (Eds.), Human tumor markers: proceedings of the International Symposium on Human Tumor Markers. ICS807 (pp. 63-74). Elsevier Science Publishers B.V..

Double minutes (DMS) and homogeneously staining regions (HSRS). / Whang-Peng, J.

Human tumor markers: proceedings of the International Symposium on Human Tumor Markers. ICS807. ed. / S.W. Ting; J.-S. Chen; M.K. Schwartz; S.W. Ting; J.-S. Chen; M.K. Schwartz. Elsevier Science Publishers B.V., 1989. p. 63-74.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Whang-Peng, J 1989, Double minutes (DMS) and homogeneously staining regions (HSRS). in SW Ting, J-S Chen, MK Schwartz, SW Ting, J-S Chen & MK Schwartz (eds), Human tumor markers: proceedings of the International Symposium on Human Tumor Markers. ICS807. Elsevier Science Publishers B.V., pp. 63-74, The International Symposium on Human Tumor Markers, 9/3/88.
Whang-Peng J. Double minutes (DMS) and homogeneously staining regions (HSRS). In Ting SW, Chen J-S, Schwartz MK, Ting SW, Chen J-S, Schwartz MK, editors, Human tumor markers: proceedings of the International Symposium on Human Tumor Markers. ICS807. Elsevier Science Publishers B.V. 1989. p. 63-74
Whang-Peng, J. / Double minutes (DMS) and homogeneously staining regions (HSRS). Human tumor markers: proceedings of the International Symposium on Human Tumor Markers. ICS807. editor / S.W. Ting ; J.-S. Chen ; M.K. Schwartz ; S.W. Ting ; J.-S. Chen ; M.K. Schwartz. Elsevier Science Publishers B.V., 1989. pp. 63-74
@inproceedings{aae0e816f5284fcbb789ca22b79899ca,
title = "Double minutes (DMS) and homogeneously staining regions (HSRS)",
abstract = "Resistance to antineoplastic drugs may develop through a variety of mechanisms. The unique mechanism for mutation to drug resistance is amplification of the gene coding for a target protein, leading to an elevated level of protein. The process of gene amplification in drug-resistant mammalian cells may occur within a single chromosome, producing an expanded homogeneously staining region (HSR) containing multiple copies of the gene coding for the target enzyme. The amplified genes may also be located in small pieces of DNA called double minutes (DMs). To study this question, we have chosen to examine the mechanisms associated with development of adriamycin resistance in the human breast cell line MCF-7. Adr(R) MCF-7 cells are 200 fold resistant to adriamycin and were produced by exposing the MCF-7 cells to increasing drug concentration through serial passages. These cells are also cross-resistrant to actinomycin D, VP-16, and vinblastine. Cytogenetic studies of the Adr(R) cell line showed the presence of HSRs on chromosome 11 and on a rearranged chromosome 7; neither were present in the parental cell lines. The HSRs became further lengthened with increasing drug concentrations. The presence of HSRs suggested that gene amplification may play a role in this resistant phenotype. Amplified DNA sequences (pA1) representing a total length of over 140 Kb were selected from Adr(R) cell DNA using in-gel hybridization techniques. Furthermore, a 3 Kb cDNA sequence pAdr1 was isolated from these cells by hybridization to each of the HSRs in the Adr(R) cells. In addition both probes hybridized to chromosome 7q21.2 in normal human lymphocytes. Both probes also exhibited some hybridization to chromosome 6pter. Thus the pAdr1 gene (a human p-glycoprotein or mdr-1 gene) resides on human chromosome 7q21.2, a region that also contains CF and C-met.",
author = "J. Whang-Peng",
year = "1989",
month = "1",
day = "1",
language = "English",
isbn = "044481065X",
pages = "63--74",
editor = "S.W. Ting and J.-S. Chen and M.K. Schwartz and S.W. Ting and J.-S. Chen and M.K. Schwartz",
booktitle = "Human tumor markers",
publisher = "Elsevier Science Publishers B.V.",

}

TY - GEN

T1 - Double minutes (DMS) and homogeneously staining regions (HSRS)

AU - Whang-Peng, J.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Resistance to antineoplastic drugs may develop through a variety of mechanisms. The unique mechanism for mutation to drug resistance is amplification of the gene coding for a target protein, leading to an elevated level of protein. The process of gene amplification in drug-resistant mammalian cells may occur within a single chromosome, producing an expanded homogeneously staining region (HSR) containing multiple copies of the gene coding for the target enzyme. The amplified genes may also be located in small pieces of DNA called double minutes (DMs). To study this question, we have chosen to examine the mechanisms associated with development of adriamycin resistance in the human breast cell line MCF-7. Adr(R) MCF-7 cells are 200 fold resistant to adriamycin and were produced by exposing the MCF-7 cells to increasing drug concentration through serial passages. These cells are also cross-resistrant to actinomycin D, VP-16, and vinblastine. Cytogenetic studies of the Adr(R) cell line showed the presence of HSRs on chromosome 11 and on a rearranged chromosome 7; neither were present in the parental cell lines. The HSRs became further lengthened with increasing drug concentrations. The presence of HSRs suggested that gene amplification may play a role in this resistant phenotype. Amplified DNA sequences (pA1) representing a total length of over 140 Kb were selected from Adr(R) cell DNA using in-gel hybridization techniques. Furthermore, a 3 Kb cDNA sequence pAdr1 was isolated from these cells by hybridization to each of the HSRs in the Adr(R) cells. In addition both probes hybridized to chromosome 7q21.2 in normal human lymphocytes. Both probes also exhibited some hybridization to chromosome 6pter. Thus the pAdr1 gene (a human p-glycoprotein or mdr-1 gene) resides on human chromosome 7q21.2, a region that also contains CF and C-met.

AB - Resistance to antineoplastic drugs may develop through a variety of mechanisms. The unique mechanism for mutation to drug resistance is amplification of the gene coding for a target protein, leading to an elevated level of protein. The process of gene amplification in drug-resistant mammalian cells may occur within a single chromosome, producing an expanded homogeneously staining region (HSR) containing multiple copies of the gene coding for the target enzyme. The amplified genes may also be located in small pieces of DNA called double minutes (DMs). To study this question, we have chosen to examine the mechanisms associated with development of adriamycin resistance in the human breast cell line MCF-7. Adr(R) MCF-7 cells are 200 fold resistant to adriamycin and were produced by exposing the MCF-7 cells to increasing drug concentration through serial passages. These cells are also cross-resistrant to actinomycin D, VP-16, and vinblastine. Cytogenetic studies of the Adr(R) cell line showed the presence of HSRs on chromosome 11 and on a rearranged chromosome 7; neither were present in the parental cell lines. The HSRs became further lengthened with increasing drug concentrations. The presence of HSRs suggested that gene amplification may play a role in this resistant phenotype. Amplified DNA sequences (pA1) representing a total length of over 140 Kb were selected from Adr(R) cell DNA using in-gel hybridization techniques. Furthermore, a 3 Kb cDNA sequence pAdr1 was isolated from these cells by hybridization to each of the HSRs in the Adr(R) cells. In addition both probes hybridized to chromosome 7q21.2 in normal human lymphocytes. Both probes also exhibited some hybridization to chromosome 6pter. Thus the pAdr1 gene (a human p-glycoprotein or mdr-1 gene) resides on human chromosome 7q21.2, a region that also contains CF and C-met.

UR - http://www.scopus.com/inward/record.url?scp=0024347736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024347736&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:0024347736

SN - 044481065X

SP - 63

EP - 74

BT - Human tumor markers

A2 - Ting, S.W.

A2 - Chen, J.-S.

A2 - Schwartz, M.K.

A2 - Ting, S.W.

A2 - Chen, J.-S.

A2 - Schwartz, M.K.

PB - Elsevier Science Publishers B.V.

ER -